A California bill headed to the governor’s desk may be the most sweeping effort in the nation to shine a light on drug pricing, but it lacks the muscle being applied in other states to directly hold those prices down.

Democratic senators are reigniting their calls to fight against another Republican health-care push that aims to repeal and replace ObamaCare after reports surfaced that President Trump and GOP leaders are working to garner support for legislation introduced by Sens. Bill Cassidy (R-La.) and Lindsey Graham (R-S.C.).

Annual family premiums for employer-sponsored health insurance rose an average of 3 percent to $18,764 this year, continuing a six-year run of relatively modest increases, according to the benchmark Kaiser Family Foundation/Health Research & Educational Trust (HRET) 2017 Employer Health Benefits Survey released today.

Health and Human Services officials have informed grass-roots groups that assist with enrollment under the Affordable Care Act that their funding will be reduced by as much as 92 percent, a move that could upend outreach efforts across the country.

Powered by increasing scrutiny of costly prescription drugs, a measure that would require sweeping new disclosure on how medicines are priced cleared its final legislative hurdle Wednesday.

California lawmakers approved several key health care proposals — and stalled on others — in their mad dash toward last Friday’s do-or-die legislative deadline.